Stan Glezer, MD, MBA is an industry physician, passionate about optimizing the value of pharmaceutical innovation for the patients, through partnering with the healthcare system.
With almost 25 years of industry experience, Dr. Glezer is a Global Vice President of Medical Affairs, Diabetes Care at Becton Dickinson. Previously, Dr. Glezer has served in a range of roles of progressively increasing responsibility, including Chief Medical Officer of a biotech company Adocia, Vice President of US Medical Affairs at Novo Nordisk Inc., etc. The highlight of his 14 years at Sanofi was the global leader of the development, regulatory submission, and launch preparation of Toujeo.
Stan has been involved in multiple initiatives in the areas of Real World Evidence, Outcomes-Based Agreements, and patient-centric business models. He brings with him extensive knowledge at an affiliate and Global level, including leadership roles in post-marketing research, epidemiology, medical communications, HEOR, interfacing with regulatory agencies, market access, marketing, sales, and overall lifecycle management.
Although his recent activities were predominantly focused on diabetes, Stan has worked in multiple therapeutic areas, including oncology, immuno-inflammation, obesity, thrombosis, bleeding disorders, rheumatology, and rare diseases. He has a strong track record of leading the teams in establishing collaborations with healthcare providers, key opinion leaders, payers, and professional associations.
Stan received his medical training in Russia and has worked in the USA, Canada, and France. He has an MBA from California Coast University and completed his graduate work in Clinical Research and Health Economics at McGill University.